Clarivate Plc

NYSE CLVT

Clarivate Plc Price to Earnings Ratio (P/E) on December 30, 2024: -2.79

Clarivate Plc Price to Earnings Ratio (P/E) is -2.79 on December 30, 2024, a 57.45% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Clarivate Plc 52-week high Price to Earnings Ratio (P/E) is -2.39 on November 15, 2024, which is 14.43% above the current Price to Earnings Ratio (P/E).
  • Clarivate Plc 52-week low Price to Earnings Ratio (P/E) is -6.83 on February 12, 2024, which is -144.85% below the current Price to Earnings Ratio (P/E).
  • Clarivate Plc average Price to Earnings Ratio (P/E) for the last 52 weeks is -4.09.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NYSE: CLVT

Clarivate Plc

CEO Mr. Matti Shem Tov
IPO Date Oct. 29, 2018
Location United Kingdom
Headquarters 70 St. Mary Axe
Employees 12,000
Sector Health Care
Industries
Description

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

Similar companies

LDOS

Leidos Holdings, Inc.

USD 152.76

0.08%

IT

Gartner, Inc.

USD 499.80

1.35%

EXLS

ExlService Holdings, Inc.

USD 45.88

-0.80%

G

Genpact Limited

USD 44.20

-0.25%

ASGN

ASGN Incorporated

USD 87.84

0.35%

CACI

CACI International Inc

USD 441.22

-1.08%

WNS

WNS (Holdings) Limited

USD 44.05

0.18%

HCKT

The Hackett Group, Inc.

USD 29.66

1.51%

SAIC

Science Applications International Corporation

USD 116.65

-1.36%

PSN

Parsons Corporation

USD 94.47

1.05%

StockViz Staff

January 15, 2025

Any question? Send us an email